North Dakota caps insulin costs at $25 for state-regulated plans
Lawmakers in Bismarck passed a bipartisan bill to limit out-of-pocket expenses for patients with Type 1 diabetes.
By Lauren Foster ·

North Dakota enacted a law last year that limits what patients pay for insulin to $25 a month. The rule applies to health insurance plans regulated by the state. It does not cover plans provided by large employers, which fall under federal jurisdiction. The measure passed with strong support from both Republican and Democratic legislators.
Ang Kritzberger, a farmer in the Red River Valley, testified in Bismarck to support the bill. Her daughter Nina has Type 1 diabetes, a condition diagnosed when Nina was seven years old. The family spends at least $8,000 annually on drugs, supplies, and medical appointments despite having insurance. Kritzberger said the new cap provides protection against future price increases.
State Sen. Sean Cleary, a Republican, co-sponsored the legislation. He argued that the market for insulin had failed to function properly for consumers. Cleary noted that Republicans typically favor free-market approaches, but this case drew broad agreement. State Sen. Tim Mathern, one of only five Democrats in the 47-member Senate, led the effort. He said he often felt isolated in his party but found common ground on this issue.
Blue Cross Blue Shield of North Dakota opposed the mandate. Lobbyist Megan Hruby told lawmakers that passing coverage mandates would raise insurance premiums for everyone else. The state chamber of commerce shared those concerns. However, supporters presented data showing that a similar cost limit for state employees had little impact on premiums. Janelle Moos, a lobbyist for AARP, said many Republican lawmakers initially believed it was not the role of government to intervene.
The national average out-of-pocket cost for insulin with private insurance was $470 in 2018. Federal data shows that figure dropped to $220 in 2025. About 40 million Americans have diabetes, and roughly one-fifth rely on insulin. The drug has been available for 100 years. Price hikes forced many patients to ration doses, a practice that can lead to hospitalization or worse.
Nina Kritzberger, now 17, manages her condition with a pump and a Dexcom monitor. She said a missed dose could cause her body to shut down. She carries spare equipment and glucose sources to manage low blood sugar. The state’s new cap joins 28 other states that have enacted similar insulin pricing limits. President Biden’s 2022 law set a $35 monthly cap for Medicare enrollees, but that provision did not extend to private insurance.
Congress is currently considering a national cap on insulin prices. Sen. Kevin Cramer, a North Dakota Republican, is among the bipartisan co-sponsors of the federal bill. A KFF survey from earlier this year found that 68% of Republicans and 77% of Democrats said there is not enough government regulation on prescription drug prices. The North Dakota law was signed into effect last year, ending a years-long debate in the state.
More News · Greensboro news · Report a business · Got a Story?






